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Cullin3-RING ubiquitin ligases are intimately linked to the unfolded protein 
response of the endoplasmic reticulum 
Abstract 
CUL3-RING ubiquitin ligases (CRL3s) are involved in diverse cellular processes through over two hundred 
BTB-domain proteins. KLHL12, a BTB-domain protein, has been suggested to play an essential role in 
export of unusually large cargo molecules like procollagen from the endoplasmic reticulum (ER). It has 
been suggested that CRL3KLHL12 mono-ubiquitinates SEC31 and mono-ubiquitinated SEC31 increases 
the dimension of a COPII coat to accommodate the large cargo molecules. As we examined this model, 
we found that functional CRL3KLHL12 was indeed critical for the assembly of large COPII structures. 
However, it did not directly affect collagen secretion, but instead influenced collagen synthesis in human 
skin fibroblasts (HSFs). These results also suggest that there is a CRL3KLHL12–independent collagen 
secretion route. Unexpectedly, CRL3KLHL12 strongly influenced the levels of sensors of the unfolded 
protein response (UPR) such as PERK and IRE1α. Interestingly, different cell lines reacted differently to 
CUL3 depletion. This cell-line dependency appears to rely on a cell-line specific BTB-domain protein(s) 
and a cell-line specific substrate(s) of the BTB-domain protein. Consistent with this idea, depletion of a 
muscle-specific BTB-domain protein KLHL41 recapitulated the effects of CUL3 depletion in C2C12 
myotubes. Based on these results we propose that CRL3KLHL12 and CRL3KLHL41 are regulators of the 
UPR sensors. 
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CUL3-RING ubiquitin ligases (CRL3s) are involved in diverse cellular processes through over 
two hundred BTB-domain proteins. KLHL12, a BTB-domain protein, has been suggested to play 
an essential role in export of unusually large cargo molecules like procollagen from the 
endoplasmic reticulum (ER). It has been suggested that CRL3KLHL12 mono-ubiquitinates SEC31 
and mono-ubiquitinated SEC31 increases the dimension of a COPII coat to accommodate the 
large cargo molecules. As we examined this model, we found that functional CRL3KLHL12 was 
indeed critical for the assembly of large COPII structures. However, it did not directly affect 
collagen secretion, but instead influenced collagen synthesis in human skin fibroblasts (HSFs). 
These results also suggest that there is a CRL3KLHL12–independent collagen secretion route. 
Unexpectedly, CRL3KLHL12 strongly influenced the levels of sensors of the unfolded protein 
response (UPR) such as PERK and IRE1α. Interestingly, different cell lines reacted differently to 
CUL3 depletion. This cell-line dependency appears to rely on a cell-line specific BTB-domain 
protein(s) and a cell-line specific substrate(s) of the BTB-domain protein. Consistent with this 
idea, depletion of a muscle-specific BTB-domain protein KLHL41 recapitulated the effects of 
CUL3 depletion in C2C12 myotubes. Based on these results we propose that CRL3KLHL12 and 
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Cullin-RING ubiquitin (Ub) ligases (CRLs) are the major E3 ligase family in eukaryotes1. A 
CRL is composed of a catalytic module and a substrate-specific adaptor module1. In CRL3s, 
CUL3 and RBX1 serve as the catalytic module and a BTB domain protein serves as the 
substrate-specific adaptor module2-4. There are 204 BTB domain genes in the human genome5, 
predicting that CRL3s are involved in various cellular processes. Indeed, recent studies have 
shown that CRL3s are important regulators of different cellular and developmental processes 
such as mitosis, cytokinesis, cell death, gene expression control, Hedgehog signaling, WNT 
signaling and so on (see Genschik et al. for review6). Defects of CRL3s have been implicated in 
metabolic diseases, dystrophies, and cancers6. 
KLHL12 is a BTB domain protein and CRL3KLHL12 plays an important role in export of 
procollagen from the endoplasmic reticulum (ER) by ubiquitinating SEC31, a component of a 
COPII coat7,8. The COPII coat consisting of SAR1, SEC23/SEC24 complex, and SEC13/SEC31 
complex is able to generate transport vesicles at the ER exit sites that can package most soluble 
and membrane proteins destined to various cellular locations. Collagens are the major 
component of the extracellular matrix (ECM). Type I and II procollagens form about 300 nm-
long rigid triple helices9,10 and require COPII proteins for export from the ER11-17. Because 
COPII proteins typically generate vesicles limited to 60-80 nm in diameter, a mechanism must 
exist that allows COPII coat proteins to accommodate such large cargo molecules. When 
KLHL12 was overexpressed, larger COPII-coated vesicles (>500 nm) were observed7 and 
collagens were found in large structures coated with SEC31 and KLHL1218. Furthermore, large 
COPII structures were generated even in the presence of lysine-free ubiquitin which prevents 
poly-ubiquitination of SEC317. Based on these results, it was proposed that mono-ubiquitinated 
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SEC31 molecules contribute to enlargement of COPII vesicles and packaging of procollagen into 
the enlarged vesicles. 
Despite the evidence for the role of KLHL12 in collagen secretion, there remains a gap in 
our understanding of CRL3s in regulation of collagen secretion. For example, although depletion 
of CUL3 profoundly disrupted a collagen deposition in the ECM in mouse embryonic stem (ES) 
cells, depletion of KLHL12 alone did not7. In contrast, depletion of COPII or TANGO-1 displays 
a profound effect on collagen deposition in the ECM or medium19-21. Thus, it is plausible that 
other BTB domain proteins also mediate the effect of CUL3 on collagen secretion or alternative 
secretion routes exist for collagen in different cells and tissues. As we investigated the proposed 
role of CUL3-KLHL12 in collagen secretion, we discovered new functions of CUL3-KLHL12 in 
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MLN4924 is a potent inhibitor of CRL3s 
The catalytic activity of CRL3KLHL12 has been shown to be critical for assembly of large COPII 
vesicles and collagen export from the ER7. To modulate the activity of CRL3KLHL12, we searched 
for small molecules that can inhibit the Ub ligase activity of CRL3KLHL12. Cullin itself is not a 
catalytic enzyme, but a scaffold protein. The Ub ligase activity of CRL3 is activated by 
neddylation of CUL3 as CUL3 neddylation induces a drastic conformational change near the 
RBX1 binding region22. This conformational change results in juxtaposition of E2-Ub to a 
substrate23,24. MLN4924 is a potent inhibitor of NEDD8-activating enzyme, resulting in strong 
inhibition of the catalytic activity of CRLs25. We used this small molecule to survey its effect on 
the catalytic activity of CRL3 and the interactions among the constituents of CRL3KLHL12. For 
this purpose, we established a doxycycline-inducible HEK cell line stably expressing FLAG 
tagged KLHL12 (KLHL12-FLAG). Interestingly, MLN4924 treatment not only prevented CUL3 
neddylation (Fig. 1A), but also stabilized KLHL12 (Fig. 1A, Input; Fig. S3, WT). This result 
suggests that turnover of KLHL12 is regulated by neddylation of CRLs. When we 
immunoprecipitated KLHL12, similar levels of SEC31 or CUL3 were co-precipitated regardless 
of inhibitor treatment (Fig. 1A, IP). Although apparent levels of SEC31 and CUL3 bound to 
KLHL12 were not affected by MLN4924 treatment, there seemed to be a decrease in the relative 
amounts of SEC31 bound to KLHL12 as there were more KLHL12 molecules due to 
stabilization. Thus, neddylation of CUL3 seems to help form CRL3KLHL12-SEC31 complex more 
effectively. 
We then asked whether MLN4924 inhibits the catalytic activity of CRL3s. Unfortunately, 
however, ubiquitinated forms of endogenous SEC31 were not detected under our experimental 
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conditions. To circumvent this problem, we took advantage of the observation that turnover of 
KLHL12 is stabilized by MLN4924 (Fig. 1A). It has been reported that an overactive form of 
CUL3 degrades KLHL3 by facilitating KLHL3 poly-ubiquitination and MLN4924 stabilizes 
KLHL3 by inhibiting CUL3-dependent KLHL3 poly-ubiquitination26. In analogy, KLHL12 may 
be ubiquitinated by CUL3.  If this is the case, MLN4924 would inhibit KLHL12 ubiquitination. 
Indeed, MLN4924 treatments inhibited ubiquitination of KLHL12 (Fig. 1B), consistent with the 
idea that CUL3 ubiquitinates KLHL12. To corroborate this idea, we generated KLHL12 
constructs with mutations at the KLHL12-CUL3 interface (Fig. S1 and Table S1, Mut B was not 
expressed for unknown reasons). Mut A or Mut C showed defects in CUL3 binding (Fig. S2A, 
B). They were also ubiquitinated with reduced efficiency (Fig. 1C). Our results indicate that 
KLHL12 ubiquitination is CUL3-dependent. Taken together, our data suggest that MLN4924 is a 
potent inhibitor of CRL3KLHL12. 
Interestingly, we noticed a strong reduction of neddylated (ned)-CUL3 bound to Mut A 
or Mut C when evaluated by immunoprecipitation (Fig. S2B).  This was not due to lack of ned-
CUL3 as we observed ned-CUL3 in total cell lysates prepared from cells stably expressing the 
KLHL12 constructs (Fig. S3). Thus, our data suggest that Mut A and Mut C do not form stable 
ned-CUL3-KLHL12 complexes. Mut A and Mut C also showed defects in KLHL12-SEC31 
interaction (Fig. S2C, D). Clearly, the KLHL12-CUL3 interface is important not only for 
KLHL12-CUL3 interaction, but also for KLHL12-SEC31 interaction. Because ned-CUL3 
species were deficient in mutant KLHL12-CUL3 complexes, this lack of ned-CUL3 in the 
complex likely contributed to the defective SEC31 binding. A similar finding was observed with 
KLHL12-SEC31 interaction in the presence of MLN4924 (Fig. 1). Note that although apparent 
levels of SEC31 and CUL3 bound to KLHL12 were not affected by MLN4924 treatment, there 
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was a decrease in the relative amounts of SEC31 bound to KLHL12 due to KLHL12 
stabilization. 
 
Formation of large COPII structures relies on functional CRL3KLHL12 
Because MLN4924 prevents neddylation of CUL3, an essential step for the activity of CRLs, we 
asked whether this inhibitor blocks the formation of large COPII-coated structures. To test this 
possibility, we treated the 293 cells stably expressing KLHL12 with MLN4924 and monitored 
COPII-KLHL12-coated structures via immunofluorescent microscopy. As previously reported, 
overexpression of KLHL12 induced formation of large COPII-KLHL12-coated structures (Fig. 
2A, DMSO panel). In the presence of MNL4924, we observed aberrant COPII-KLHL12 
structures with reduced SEC31 signals (Fig. 2A, MLN4924 panels), suggesting that the catalytic 
activity of CRL3KLHL12 is necessary for formation of large COPII coats. 
 We also monitored large COPII structures induced by expression of Mut A or Mut C 
(Fig. 2B). Interestingly, Mut A induced formation of apparently normal COPII-KLHL12 
structures except that intensities of SEC31 fluorescence were slightly weaker than those of WT 
(Fig. 2B). Mut C induced formation of elongated COPII-KLHL12 structures with strongly 
reduced SEC31 fluorescence. These results reflect reduced interactions between the mutant 
KLHL12s and SEC31 (Fig. S2C, D). Taken together with the MLN4924 results, our data suggest 
that a proper KLHL12-CUL3 interaction and CUL3 neddylation are important for formation of 
large COPII-KLHL12 structures. 
 
MLN4924 reduces intracellular levels of, but not secretion of collagen 
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Since MLN4924 treatment induced the formation of aberrant structures, we expected that this 
inhibitor reduces collagen secretion. We used human dermal fibroblasts (HSFs) which secrete 
type I collagen robustly because the 293 cells do not express type I collagen (Fig. S4). 
Intracellular collagen molecules were efficiently depleted within 3h in HSFs when new collagen 
synthesis was blocked (Fig. 3A). MLN4924 treatment inactivated CRL3s as indicated by the 
absence of ned-CUL3 (Fig. 3B, see the CUL3 panel). Unexpectedly, however, secretion of 
collagen was not affected by MLN4924 treatments (Fig. 3B and C), but the levels of intracellular 
collagen were reduced by the inhibitor treatments (Fig. 3B and D). Although the deposition of 
collagen in the medium was not attenuated despite the reduction of intracellular collagen levels 
by 24h, prolonged inhibitor treatments (> 24h) eventually blocked additional deposition of 
collagen in the medium (Fig. S5, see 48h and 72h). This was due to complete absence of 
collagen in the cells. These data suggest that CRLs primarily regulate cellular collagen levels. 
While our data gave us an interesting clue toward a new role of CUL3 in collagen, we did 
recognize that MLN4924 influences different CRLs and may also interact with unknown targets. 
 
CUL3 is a regulator of collagen synthesis 
To test if CUL3 is indeed responsible for regulation of collagen levels we used an approach of 
RNA interference (RNAi) with small interfering RNAs (siRNAs) (Fig. 4A, B). Initially, we 
performed RNAi in the absence of fetal bovine serum during the transfection step (16 h) where 
cells were exposed to transfection reagents. Subsequently, we realized that inclusion of the 
serum during this step yielded more robust results. When the serum was present during the 
transfection step, intracellular collagen levels increased (Fig. 4A, C)(compare lane 1 with lane 3; 
lane 2 with lane 4). This result is consistent with previous reports that the serum enhances 
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synthesis of type I collagen in HSFs27,28. Depletion of CUL3 enhanced the levels of intracellular 
and secreted collagen especially when the serum was present (Fig. 4A, C, D)(compare lane 3 
with lane 4). This was unexpected because the MLN4924 treatment reduced collagen levels. 
However, considering the inhibitory activity of MLN4924 on the NEDD8-activating enzyme and 
diverse cellular processes governed by the NEDD8-activating enzyme, we concluded that CUL3 
RNAi is more specific than the MLN4924 treatment. 
The increase in levels of secreted and intracellular collagen suggests that collagen gene 
expression is increased by CUL3 depletion. To test this possibility, we measured levels of 
COL1A1 mRNAs with a real time quantitative PCR (RT-qPCR) (Fig. 4E). As expected, we 
observed about 7-fold increase in the levels of COL1A1 mRNAs by CUL3 depletion. These 
results indicated that CUL3 regulates synthesis of COL1A1. 
 
CUL3 is a regulator of the unfolded protein response (UPR) of the ER 
It was intriguing that the effect of CUL3 RNAi on collagen became significant when the serum 
was present and that the effect of CUL3 RNAi on collagen was lost when the serum is absent. 
Serum provides cells with growth factors that stimulate collagen synthesis29. It has been also 
reported that a serum deprivation can induce ER stress (i.e., the UPR), which leads to inhibition 
of collagen synthesis in HSFs30. However, because we added back the serum after the 
transfection step and continued to incubate the cells in a serum containing medium for 48h, ER 
stress triggered by the serum withdrawal would be limited. Nevertheless, we tested whether our 
serum withdrawal procedure could trigger ER stress, masking the effect of CUL3 RNAi on 
collagen. For this purpose, we monitored changes in the levels of the UPR sensors such as 
PERK, IRE1α, and ATF6α31. Remarkably, CUL3 RNAi led to an increase in the levels of PERK 
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and IRE1α, but not those of full-length (FL) ATF6α. (Fig. 4A, F, G). Note that ATF6α FL is 
transported from the ER to the Golgi where it is processed to the N-terminal fragment (NTF) 
when the UPR is activated32. Phosphorylation of eIF2α, a downstream molecule of the PERK 
signaling pathway33, was enhanced by CUL3 RNAi (Fi.g 4A, H). This enhancement became 
quite significant when the serum was present. However, when serum was absent, 
phosphorylation of eIF2α was not enhanced by CUL3 RNAi with strong statistical significance 
even though the levels of PERK and IRE1α were increased. Perhaps this was due to a low signal 
to noise ratio of p-eIF2α under the condition. However, it was clear that our serum withdrawal 
procedure did not trigger ER stress by itself (Fig. 4, compare lane 1 with lane 3 for PERK, 
IRE1α, p-eIF2α, and ATF6α). It should be noted that phosphorylation of eIF2α was enhanced 
by CUL3 RNAi even in the absence of extrinsic ER stressors such as DTT, thapsigargin, and 
tunicamycin. These results suggest that CUL3 modulates levels of UPR sensors such as PERK 
and IRE1α and that CUL3 regulates PERK signaling. 
 We then asked whether the increase in the amounts of PERK and IRE1α leads to an 
overactivation of the UPR when cells are stressed with an extrinsic ER stressor. For this purpose, 
we treated HSFs with DTT (Fig. 5). DTT treatments retarded the mobility of PERK and IRE1α 
in SDS-PAGE (Fig. 5A). These shifts in mobility have been shown to be caused by 
phosphorylation34. The levels of PERK and IRE1α species including the slowly migrating ones 
were increased by CUL3 RNAi upon DTT treatments, but not those of ATF6α-FL, suggesting 
that UPR signaling branches involving PERK and IRE1α are upregulated (Fig. 5 A, C-E). We 
also monitored changes in downstream components of the UPR. Although phosphorylation of 
eIF2α was enhanced by CUL3 RNAi alone, the DTT treatments did not further enhance 
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phosphorylation of eIF2α (Fig. 5A, F). XBP1 is a critical component of the IRE1α pathway and 
a UPR induction triggers synthesis of the spliced form of XBP135,36. The DTT treatments 
induced synthesis of spliced XBP1 as expected (Fig. 5A). CUL3 RNAi combined with DTT 
treatments led to a significant increase of spliced XBP1 compared to the DTT treatments alone 
(Fig. 5A, G). CUL3 depletion did not change the levels of ATF6α-NTF (Fig. 5A, H). Based on 
these observations we concluded the CUL3 is also an important regulator of IRE1α signaling in 
HSFs. 
There are 204 BTB domain genes which likely serve as a substrate-specific adaptor for 
CUL3 in the human genome5. Different cell lines/tissues are expected to have different profiles 
of BTB-domain proteins. Thus, we asked if the newly found CUL3-UPR link is observed in 
different cell types. To address this question we performed RNAi in IMR90 and HeLa (Fig. 6). 
The effects of CUL3 depletion on IRE1α and PERK were observed in IMR90 (Fig. 6 A and B). 
Interestingly, CUL3 RNAi increased levels of PERK but not those of IRE1α in HeLa cells (Fig. 
6A and C), indicating that CUL3 does not always regulate levels of PERK and IRE1α 
concurrently. Our results are consistent with the idea that CUL3 regulates the levels of PERK 
and IRE1α with at least two different BTB domain proteins that are differentially expressed in 
HSFs, IMR90, and HeLa (Fig. 6D). 
 
KLHL12 regulates collagen levels and the UPR 
We then tested whether the effects of CUL3 on collagen and the UPR is mediated through 
KLHL12 in HSFs. KLHL12 RNAi led to a reduction of secreted as well as intracellular collagen 
(Fig. 7A-D). It is intriguing that CUL3 depletion and KLHL12 depletion resulted in opposite 
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outcomes with respect to collagen synthesis. This result suggests a complexity in regulation of 
collagen synthesis by CUL3 and its adaptors. Regardless, KLHL12 does not influence collagen 
secretion directly, rather does so probably by affecting collagen synthesis. Interestingly, 
KLHL12 RNAi led to an increase in the levels of PERK and IRE1α when the serum was present 
during transfection, but not when the serum was absent during transfection (Fig. 7A, E, F). We 
believe this is partly due to inefficiency of KLHL RNAi under the condition (Fig. 7B). Thus, we 
identified a new function of CRL3KLHL12 that it regulates the levels of collagen and UPR sensors. 
 
CUL3 and a muscle-specific BTB domain protein regulate PERK levels 
While we examined the effect of CUL3 depletion in various cell types, we noticed that PERK 
levels were reduced by CUL3 depletion in C2C12 mouse myotubes (CMTs) (Fig. 8). Levels of 
IRE1α were not affected by CUL3 RNAi. This response is likely due to myotube-specific BTB 
domain proteins. As an effort to identify such BTB-domain proteins, we took advantage of the 
observations that KLHL41 is the most abundant BTB-domain protein in CMTs37, it is a muscle-
specific protein38, and it interacts with CUL339. Depletion of KLHL41 resulted in similar 
responses to depletion of CUL3 (Fig. 8), supporting the notion that the muscle-specific effect of 
CUL3 on the UPR is conveyed through the muscle-specific BTB domain protein KLHL41. 
Based on these results we conclude that CRL3KLHL41 is a regulator of PERK in muscle cells. 
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Our data support the idea that the integrity of CRL3KLHL12 is critical for formation of KLHL12-
COPII-coated structures as MLN4924 treatments or KLHL12 mutants compromised KLHL12-
COPII structures. Surprisingly, depletion of CUL3 or KLHL12 affected collagen levels in the 
cell as well as in the culture medium when the siRNA transfection was performed in the presence 
of the serum in HSFs. However, similar depletion did not influence secretion, nor intracellular 
levels of collagen when the siRNA transfection was performed in the absence of the serum. 
Although the physiological relevance of these two in vitro conditions remains to be determined, 
a quantitative proteomic study has revealed that levels of COL2A1 and COL9A1 are enhanced in 
skeletal muscles of skeletal muscle-specific CUL3 knockout mice40. Apparently, CUL3 plays a 
role in regulating collagen synthesis and there seems to exist a CUL3/KLHL12-independent 
collagen secretion pathway in vitro and in vivo. Thus, these results are inconsistent with the 
model that CRL3KLHL12 is essential for collagen export. However, our data do not exclude a 
possibility that there is a CRL3KLHL12–dependent collagen secretion pathway under a specific 
condition (i.e., early embryonic development). Perhaps, multiple mechanisms are present to 
export collagen from the ER. 
One of the salient aspects of our findings is that CUL3 regulates the UPR. Because of the 
enhanced levels of PERK and IRE1α due to CUL3 depletion in HSFs, downstream UPR 
signaling was activated accordingly, indicating that CUL3 regulates UPR signaling. Although 
the effect of CUL3 on collagen synthesis was influenced by the serum, the effect of CUL3 on the 
UPR sensors was not affected by the serum. These results suggest that the CUL3-UPR 
interaction is independent of the serum-induced ER stress. 
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CUL3 depletion led to about 2-fold increase of COL1A1 proteins and about 7-fold 
increase of COL1A1 mRNAs. These results suggest that there is a translational block under this 
condition. Perhaps enhanced PERK-eIF2α signaling induced by CUL3 depletion accounts for 
this inhibitory effect because it is well established that p-eIF2α inhibits translation of mRNA 
into protein33. 
If CUL3 triggered ER stress in a similar way to an ER stressor like DTT, tunicamycin, 
and thapsigargin, we would have observed an activation of all three signaling routes of the UPR. 
However, ATF6α levels and its proteolytic processing were not affected by CUL3 depletion. 
Thus, we do not think CUL3 depletion works in a similar way to the ER stressors. In addition, 
those ER stressors do not alter the levels of the UPR sensors, but instead shift the molecular 
weight (band smearing due to phosphorylation) (Fig. 5A, compare lane 1 with lane 2 or lane 3 
for PERK and IRE1α). Our results are consistent with the idea that CUL3 influences the UPR 
specifically (i.e., PERK and IRE1α). This specific effect likely involves a specific BTB domain 
protein(s) and its cell line-specific substrate molecule (i.e., a transcription activator or a 
repressor). Although we have not found a cell line where CUL3 regulates ATF6, it is formally 
possible that CUL3 regulates ATF6 in a certain cell line. 
KEAP1, a BTB-domain protein, regulates UPR signaling involving NRF241. NRF2 is a 
transcription factor which regulates the expression of antioxidant genes in response to oxidative 
stress42,43. NRF2 levels are maintained via association with KEAP144. This association is 
regulated by PERK-dependent phosphorylation of NRF245. This mode of UPR regulation by 
KEAP1 is distinct from the newly identified mode of UPR regulation by CUL3 where CUL3 
regulates PERK and IRE1α. Thus, CUL3 and its adaptor molecules influence the UPR with 
multi-faceted strategies, emphasizing fundamental importance of CUL3 in UPR regulation. 
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We discovered that CUL3 regulates UPR sensors in a cell line-specific manner: 1) CUL3 
depletion increased levels of PERK and IRE1α in HSF and IMR90, 2) CUL3 depletion increased 
levels of PERK, but not those of IRE1α in HeLa cells, and 3) CUL3 depletion reduced levels of 
PERK, but not those of IRE1α in CMTs. We believe that this cell-type specificity arises due to 
differentially expressed BTB-domain proteins and their substrate(s). CUL3 recognizes its 
substrate molecules through a BTB-domain protein6. Two hundreds and four BTB-domain genes 
are likely expressed in a tissue-specific manner in human cells5. In fact, KLHL41 is expressed 
exclusively in muscles46. The cellular phenotypes induced by depletion of KLHL41 were similar 
to those induced by depletion of CUL3 in CMTs, suggesting that the effect of CUL3 is relayed 
through KLHL41. In addition, a BTB-domain protein can recognize several different target 
molecules, vastly expanding functional roles of CUL3. Importance of tissue-specific expression 
of a substrate molecule(s) of KLHL41 was also obvious in our data. Mere absence of KLHL41 is 
not sufficient to lower the levels of PERK because PERK levels are relatively high in cell lines 
(i.e., HSFs) which do not express KLHL41. In addition, although KLHL41 is expressed much 
less in myoblasts than in myotubes, the levels of PERK are quite high in myoblasts compared to 
those in myotubes (Fig. 6S, compare day 0 to day 2-5). Thus, a myotube-specific substrate(s) of 
KLHL41 likely plays a critical role in PERK regulation. It is possible that this substrate molecule 
regulates PERK levels through a synthetic or a degradative mechanism. The identity of the 
substrate remains to be determined. 
BTB-domain proteins are necessary for a proper muscle function. Mutations of KLHL40, 
KLHL41, and KBTBD13 cause nemaline myopathy47-49. KLHL9 is associated with a distal 
myopathy in humans50. KLHL31 is linked to a congenital myopathy in mice51. Furthermore, 
muscle-specific deletion of CUL3 disrupts muscle physiology profoundly, highlighting the 
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fundamental importance of CUL3 and its substrate-specific adaptor molecules in muscle 
functions40. Interestingly, a quantitative proteomic analysis of mice with a TPM3 mutation 
showed about a 3-4 fold reduction of PERK (a.k.a. EIF2AK3) in the diaphragm muscles52. TPM3 
mutations also cause nemaline myopathy in humans53. Perhaps UPR dysregulation is common in 
a subset of nemaline myopathy and related congenital myopathies. 
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Plasmid and siRNA 
The pcDNA5/FRT/TO KLHL12-FLAG construct was a gift of Michael Rape’s laboratory 
(University of California, Berkeley, CA, USA). The KLHL12 Mut A (ELSE65-68AAAA), Mut 
B (CLLQLK111-116AAAAAA), and Mut C (FAETHNC141-147AAAAAAA) were generated 
by site-directed mutagenesis (Fig. S1 and Table S1). pCMV6-Entry (PS100001), human 
pCMV6-KLHL40-Myc-DDK (RC213832), and human pCMV6-KLHL41-Myc-DDK 
(RC200295) were purchased from Origene (Rockville, MD, USA). The control (D-01910-10-
50), human–specific CUL3 (M-010224-02), and KLHL12 siRNAs (M-015890-02), mouse-
specific CUL3 (M-062951-01-0005), KLHL40 (M-016211-02-0005), and mouse-specific 
KLHL41 (M-045964-01-0005) were purchased from Dharmacon (Lafayette, CO, USA). 
Sequences of these siRNAs are shown as follows. Control (pool of 4) siRNAs: 5’-
UAGCGACUAAACACAUCAA-3’, 5’-UAAGGCUAUGAAGAGAUAC3’, 5’-
AUGUAUUGGCCUGUAUUAG-3’, 5’-AUGAACGUGAAUUGCUCAA-3’. Human CUL3 
(pool of 4) siRNAs: 5’- CCGAACAUCUCAUAAAUAA-3’, 5’-
GAGAAGAUGUACUAAAUUC-3’, 5’-GAGAUCAAGUUGUACGUUA-3’, 5’-
GCGGAAAGGAGAAGUCGUA-3’. Mouse CUL3 (pool of 4) siRNAs: 5’- 
GAAAGUAGAAGCUAGGAUU-3’, 5’- CGGCAAACUUUAUUGGAUA-3’, 5’- 
GGUGAUGAUUAGAGACAUA-3’, 5’- CCAAGUCCAGUUGUUAUUA-3’. Human KLHL12 
(pool of 4) siRNAs : 5’-GGAAGGUGCCGGACUCGUA-3’, 5’-
GCGCUAUGAUCCAAACAUU-3’, 5’-GAAGAAUCCUUGCCUAACC-3’, 5’- 
UAAUCAAGUGCGACGAAAU-3’. Mouse KLHL40 (pool of 4) siRNAs: 5’-
GCGCAUACUUCCUGCAGUU-3’, 5’-GAACAAGAUGUGCGUCUAU-3’, 5’-
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CUACGUAAUUGGCGGCAAA-3’, 5’-AUGAGGAGGCCGAACGUAU-3’. Mouse KLHL41 
(pool of 4) siRNAs: 5’-GGGAAGUGAUGACGGAAUU-3’, 5’-GUUCAUCAUUGCACCCUA-
3’, 5’-GGCAUGGAAUGUUUGUUAA-3’, 5’-CCGGUUACCUGAACGAUAU-3’ 
 
Antibodies and chemicals 
Rabbit anti-PC1 antibodies were a gift from L. Fisher (LF-68, 1:8000, National Institute of 
Dental and Craniofacial Research, Bethesda, MD, USA)54. Rabbit anti-ribophorin I antibody 
(1:5,000) was a gift from Schekman laboratory (University of California, Berkeley, CA, USA). 
Additional antibodies we used include rabbit anti-CUL3 (A301-109A, 1:1000, Bethyl 
Laboratories, Universal Biologicals, Cambridge, UK), mouse FK2 anti-Ub (BML-PW8810, 1: 
1000, Enzo Life Sciences, Farmingdale, NY, USA), anti-FLAG (F3165, F7425, 1:1500, Sigma-
Aldrich, St. Louis, MO, USA), mouse anti-KLHL12 (#30058, 1:1000, ProMab Biotechnology, 
Richmond, CA,USA), rabbit anti-KLHL40 (#HPA024463, 1:1000, Sigma-Aldrich, St. Louis, 
MO, USA), rabbit anti-KLHL41 (#AV38732, 1:1000, Sigma-Aldrich, St. Louis, MO, USA), 
mouse and rabbit anti-SEC31A (#612350, BD Biosciences, San Diego, CA, A302-336A, Bethyl 
Laboratories, Universal Biologicals, Cambridge, UK), rabbit anti-IRE1α (#3294), PERK 
(#5683), p-eIF2α (Ser51, #9721), total-eIF2α (#9722), XBP-1s (#12782) (1:1000 final dilution; 
all from Cell signaling Technology, Danvers, MA, USA), monoclonal anti-ATF6α antibody (73-
500, 1:1200, B-Bridge International, Inc., Santa Clara, CA, USA), monoclonal anti-α-tubulin 
(TU-02, sc-8035, 1:2000, Santa Cruz Biotechnology, Dallas, TX, USA). Hygromycin B (10687-
010) and blasticidin S (R210-01) were purchased from Invitrogen (Carlsbad, CA, USA).  
Cycloheximide (CHX, C4859), dimethyl sulfoxide (DMSO, D4540,) and 1, 4-dithiothreitol 
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(DTT, D0632) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Protease inhibitor 
cocktail (Mannheim, Germany), MLN4924 (15217, Cayman Chemical, Ann Arbor, MI, USA), 
MG132 (474790, Calbiochem, San Diego, CA, USA), brefeldin A (BFA, #9972, Cell signaling 
Technology, Danvers, MA, USA) were also used. 
 
Cell culture and transfection 
Normal human foreskin fibroblasts (CRL-2091), HeLa cells (HeLa, CCL-2), human lung 
fibroblasts (IMR-90, CCL-186), and mouse C2C12 myoblasts (CRL1772) were purchased from 
the American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were maintained in 
low-glucose Dulbecco’s Modified Eagle Medium (DMEM) with 10% fetal bovine serum (FBS) 
and 1% penicillin–streptomycin. Flp_In T-RExTM 293 host cell line containing a stably 
integrated FRT site and tetracycline (Tet) repressor was grown in high-glucose DMEM, 
supplemented with 10% FBS, blasticidin and hygromycin B as instructed by the manufacturer 
(Gibco/Thermo Fisher, Waltham, MA, USA) and gene expression was induced by 1 µg/ml 
doxycycline. Cells were maintained in high-glucose Dulbecco’s Modified Eagle Medium 
(DMEM) with 10% fetal bovine serum (FBS) and 1% penicillin–streptomycin for proliferation 
(Gibco/Thermo Fisher, Waltham, MA, USA). Differentiation C2C12 myoblasts into myotubes 
was initiated by incubating the cells in high-glucose Dulbecco’s Modified Eagle Medium 
(DMEM) with 2 % Horse serum (HS) (Thermo Fisher, Waltham, MA, USA) and 1% penicillin-
streptomycin55. Cell lines were maintained in a water jacketed incubator at 37°C with 5% CO2 
enrichment. Lipofectamine LTX 3000 was used for plasmid DNAs transfection and 
Lipofectamine RNAiMAX for siRNAs transfection according to the manufacturer’s protocols 
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unless specified otherwise. All of the cell culture and transfection reagents were purchased from 
Invitrogen (Carlsbad, CA, USA). 
 
Establishing stable cell lines 
Flp-In™ T-REx™ 293 cells stably expressing Tet-inducible KLHL12 WT, Mut A, and Mut C 
were generated according to the manufacturer’s instructions (Flp-In™ System, Invitrogen, 
Carlsbad, CA, USA). Briefly, the Flp-In™ T-REx™ 293 Cells (R780-07) were plated onto 6-
well plates and incubated for 24 h. The following day, the cells were transfected using 5 µl 
Lipofectamine LTX with 0.5 µg of a KLHL12 construct and 1.0 µg of pOG44 (V6005-20). After 
48 h post-transfection, the cells were replated on 24-well plates and subjected to selection with 
hygromycin B (100 µg/ml) and blasticidin S (10 µg/ml) for up to 4 weeks and KLHL12 
expression was induced by 1 µg/ml doxycycline. 
 
Co-immunoprecipitation and Immunoblotting 
For co-immunoprecipiation, cells were collected by centrifugation and lysed by douncing 30 
times using buffer A (0.1% NP-40, 2.6 mM KCl, 1.5 mM KH2PO4, 140 mM NaCl, 8 mM 
Na2HPO4-7H2O, and 1X protease inhibitor cocktail) on ice. After centrifugation for 15 min at 
14,000 rpm at 4°C, cleared lysates were incubated with indicated antibodies overnight in the cold 
room, followed by incubation with protein A or protein G Sepharose beads (GE Healthcare, 
Milwaukee, WI, USA) for 3 h with gentle rocking in the cold room. The beads were harvested by 
centrifugation and washed three times with buffer A. After adding the SDS-sample buffer and 
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heating for 5 min at 95 °C, proteins were resolved with SDA-PAGE and processed for 
immunoblotting. 
For routine immunoblotting analysis, cells were lysed with buffer B (20 mM Tris-HCl, pH 7.5, 
150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5 mM 
sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na3VO4, 1X complete protease 
inhibitor cocktail) on ice for 15 minutes. Cell lysates were cleared by centrifugation at 14,000 
rpm for 15 minutes at 4°C. Cleared lysates were quantified using Pierce BCA Protein Assay Kit 
(Thermo Fisher Scientific, Waltham, MA, USA). Equal amounts of proteins were resolved on 6 
or 10% SDS-PAGE, transferred to PVDF membrane (Millipore, Bedford, MA, USA), probed 
with primary antibodies, subsequently with horseradish peroxidase-conjugated secondary 
antibodies, and visualized with ECL Prime (GE Healthcare, Pittsburgh, PA, USA). Band 
intensity was quantified using the ImageJ software. Protein levels were normalized to ribophorin 
I or α-tubulin and are presented as mean ± standard deviation. 
 
Ubiquitination assay 
The ubiquitination assay was performed as previously described56. Briefly, Tet-inducible 
KLHL12-FLAG-expressing 293 cells were treated with MG132 for 24 h prior to harvest. To 
assess endogenous ubiquitination of KLHL12, cells were harvested in PBS containing 5 mM 
NEM and lysed in 1% SDS by boiling for 10 min. Cell lysates were diluted to 0.1% SDS by 
adding lysis buffer (6 M guanidinium-HCl buffer (pH 8.0)) containing protease inhibitors and 5 
mM NEM, and immunoprecipitated with anti-FLAG antibody followed by immunoblot. 
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Immunofluorescent microscopy  
Cells were plated in 6-well plate with acid-washed glass coverslips. After 24h, cells were fixed 
with 4% paraformaldehyde (PFA) in DPBS for 30 min, washed five times with PBS and 
permeabilized with 0.1% Triton X-100 in DPBS for 15 min at room temperature. Primary 
antibodies were used in 0.5% BSA in DPBS. Cells were incubated with blocking buffer (0.5% 
BSA in PBS) for 30 min at RT followed by 1 h incubation at RT with rabbit anti-FLAG antibody 
(1:500, Sigma-Aldrich, St. Louis, MO, USA) and mouse anti-SEC31A antibody (1:500, BD 
Biosciences, NJ, USA) and then secondary antibodies such as Alexa Fluor 488 goat anti-rabbit 
IgG and Alexa Fluor 594 goat anti-mouse IgG (1:500, Molecular Probes, Invitrogen, Carlsbad, 
CA, USA). Antibody incubations were followed by five PBS washes. Images were obtained 
using a confocal laser microscopy (Nikon C1, Nikon, Tokyo, Japan), and merges of images were 
processed using Nikon EZ-C1 viewer software. 
 
Real-time quantitative PCR with reverse transcription  
RNA was obtained from fibroblast cells using Trizol reagent (Invitrogen, Carlsbad, CA, USA) 
according to the manufacturer's instructions. Complementary DNAs (cDNAs) were synthesized 
from total RNA using Superscript II First-strand Synthesis kit (Invitrogen, Carlsbad, CA, USA) 
and quantified by real-time PCR using the IQ SYBR green supermix kit (Bio-Rad Laboratories, 
Hercules, CA, USA) and the following primers: human COL1A1, 5’-GTGTTGTGCGSTGSCG-
3’ and 5’-TCGGTGGGTGACTCT-3’; human CUL3, 5’-CTGGTGTATCTTTAGGTGGTG-3’ 
and 5’-GTGCTGGTGGGATGTTG-3’; human GAPDH, 5’-CTCCTCCACCTTTGACGC-3’ and 
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5’-CCACCACCCTGTTGCTGT-3’. Gene expression levels were normalized to GAPDH 
expression levels. 
 
Statistical analysis  
Statistical analyses were performed using GraphPad Prism (GraphPad Software Inc., La Jolla, 
CA, USA). The results of multiple experiments were presented with mean ± standard deviation 
(SD). P-values of less than 0.05 were considered statistically significant. 
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Figure 1.   MLN4924, an inhibitor of NEDD8-activating enzyme, inhibits the activity of 
CRL3KLHL12. (A and B) 293 cells stably expressing KLHL12-FLAG were incubated in the 
presence or absence of MLN4924. Expression of KLHL12-FLAG was induced with 
doxycycline. Cellular lysates were processed for immunoprecipitation using an anti-FLAG 
antibody. Closed arrowhead, neddylated CUL3; open arrowhead, unneddylated CUL3. 
*Nonspecific band. **Immunoglobulins. (C) An HA-tagged ubiquitin construct was expressed in 
HEK cells stably expressing wildtype (WT) or a mutant KLHL12 (Mut A or Mut C). Cellular 
lysates were processed for immunoprecipitation using an anti-FLAG antibody. 
 
Figure 2. Aberrant large COPII structures with compromised CRL3KLHL12. (A) 293 cells 
stably expressing WT KLHL12-FLAG were incubated in the presence (1µM) or absence 
(DMSO) of MLN4924 and processed for immunofluorescent labeling. Labeled cells were 
visualized by standard confocal microscopy. Aberrant large COPII-KLHL12 structures were 
formed upon the MLN4924 treatment. (B) 293 cells stably expressing the indicated construct 
were processed for immunofluorescent labeling.  Labeled cells were visualized by standard 
confocal microscopy. Large structures that are co-stained with KLHL12 and SEC31A were 
marked with closed arrowheads. Those that are deficient with SEC31A labeling were marked 
with open arrowheads. 
 
Figure 3.   Regulation of cellular COL1A1 levels by MLN4924. (A) Rapid depletion of 
intracellular collagen was observed in human skin fibroblasts (HSFs) after cycloheximide 
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treatment. (B) HSFs were plated and incubated for 24h. Afterwards, the culture medium was 
replaced with fresh medium with or without MLN4924 (1µM). Conditioned media and cells 
were collected at indicated times and processed for immunoblotting. The amount of a medium 
loaded into the gel was normalized to the amount of total proteins in a cell lysate. Riboporin I 
was probed as a loading control. Medium, unconditioned medium; closed arrowhead, ned-CUL3; 
open arrowhead, unneddylated-CUL3. (C, D) Quantification of levels of secreted (C) and 
intracellular (D) collagen. Protein bands were quantified using ImageJ. Student’s t-test: P*<0.05, 
n=3. (E, F) Depletion of KLHL12 (E) or CUL3 (F) by siRNA. Asterisks represent nonspecific 
proteins. Occasionally, a proteolytic processing of collagen occurs in the secreted collagen, 
resulting in a fast migrating species (open arrowheads). Note that the reduction in the levels of 
KLHL12 or CUL3 already reached the maximum at the lowest siRNA concentration used. 
  
Figure 4. Regulation of COL1A1, PERK, and IRE1α levels by CUL3. (A-G) HSFs were 
transfected with scrambled (Scr) or CUL3 siRNAs. When the cells were incubated with siRNAs 
and transfection reagents (about 16 h), 10% FBS was absent or present as indicated. The culture 
medium was then replaced with a fresh complete medium containing 10% FBS. The cells and the 
conditioned media were collected after additional 48 h of incubation. (A) A representative 
immunoblot images. (B-D, F-H) Immunoblots images of 4-5 independent experiments were 
quantified. Statistical analyses were performed with Student’s t-test. Error bars represent 
standard deviations. (B) Comparison of CUL3 levels normalized to α-tubulin. P*<0.0005; 
P**<0.0001, n=5. (C) Comparison of intracellular COL1A1 levels. P*<0.0001; P**<0.01, n=5. 
n.s., non-significant. (D) Comparison of secreted COL1A1 levels. P*<0.005, n=5. n.s., non-
significant. (E) Levels of COL1A1 mRNAs were measured with RT-qPCR and normalized to 
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levels of GAPDH mRNAs. P*<0.005, n=7. (F) Comparison of PERK levels. P*<0.0005; 
P**<0.0001, n=5. (G) Comparison of IRE1α levels. P*<0.0005; P**<0.0001, n=5. (H) 
Comparison of phosphorylated (p)-eIF2α levels normalized to total levels of eIF2α. P*=0.001, 
n=4. n.s., non-significant. 
 
Figure 5. Regulation of IRE1α-signaling by CUL3. (A) HSFs were transfected with 
scrambled (Scr) or CUL3 siRNAs in the presence of the serum. Cells were treated with 2 mM 
DTT for an indicated duration. (A) A representative immunoblot images. Upon a DTT treatment, 
bands of PERK and IRE1α migrated slower than those in the untreated condition due to 
phosphorylation34. (B-H) Immunoblots images of 3 independent experiments were quantified. 
Statistical analyses were performed with Student’s t-test. Error bars represent standard 
deviations. (B) Comparison of CUL3 levels (normalized to α-tubulin) between presence and 
absence of DTT at each time point. P*<0.0001; P**<0.005, n=3. (C) Comparison of PERK 
levels between presence and absence of DTT at each time point. P*<0.005; P**<0.01, n=3. Note 
that band smearing prevented faithful quantification at 3h. (D) Comparison of IRE1α levels. 
P*<0.0001; P**<0.005; P***<0.0005, n=3. (E) Comparison of ATF6α levels. (F) Comparison 
of p-eIF2α levels normalized to total levels of eIF2α. P*<0.05, n=3. (G) Comparison of spliced 
(s) XBP1 levels.  P*<0.05; n=3. (H) Comparison of ATF6α NTF levels.  
 
Figure 6. A tissue-specific regulation of the UPR by CUL3. (A, B, and C) Different cell 
lines were transfected with scrambled (Scr) or CUL3 siRNAs in the absence of the serum. 
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Immunoblots were quantified for IMR90 cells (B) and for HeLa cells (C). Statistical analyses    
were performed with Student’s t-test. Error bars represent standard deviations. (B) P*<0.05, 
P**<0.0001, n=4. (C) P*<0.05; P**<0.005, n=4. (D) A model explaining the cell line-specific 
regulation of the UPR by CUL3 and its adaptors. TC, transcription; TL, translation. 
 
Figure 7. Regulation of COL1A1, PERK, and IRE1α levels by KLHL12. HSFs were 
transfected with scrambled (Scr) or KLHL12 (K12) siRNAs as described in the legend of Fig. 4. 
(A) A representative immunoblot images. (B-F) Immunoblots images of 3 independent 
experiments were quantified. Statistical analyses were performed with Student’s t-test. Error bars 
represent standard deviations. (B) Comparison of KLHL12 levels normalized to α-tubulin. 
P*<0.0005; n=3. Note that KLHL12 levels were increased in the presence of the serum for 
unknown reasons. (C) Comparison of intracellular COL1A1 levels. P*<0.005, n=3. (D) 
Comparison of secreted COL1A1 levels. P*<0.05, n=3. (E) Comparison of PERK levels. 
P*<0.0001, n=3. n.s., non-significant. (F) Comparison of IRE1α levels. P*<0.0001, n=3. 
 
Figure 8. KLHL41 is responsible for PERK regulation in C2C12 mouse myotubes (CMTs). 
C2C12 mouse myoblasts were transfected with scrambled (Scr) or indicated siRNAs in a 
differentiation medium at day 0. The medium was replaced with a fresh differentiation medium 
at day 1. Cells were harvested at day 3. (A) A representative immunoblot images. For unknown 
reasons, a depletion of CUL3 led to a reduction of KLHL41 levels, but not vice versa. (B-E) 
Quantifications of 3 independent experiments were plotted. Statistical analyses were performed 
with Student’s t-test. Error bars represent standard deviations. We were not able to measure 
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COL1A1 levels because its expression was dramatically reduced in myoblast subcultures. (B) 
Comparison of CUL3 levels (normalized to α-tubulin). P*<0.005, n=3. (C) Comparison of 
KLHL41 levels. P*<0.01, P**<0.0001, n=3. (D) Comparison of PERK levels. P*<0.005, 
P**<0.0001, n=3. (E) Comparison of IRE1α levels. 
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